What Fluidic Analytics does

Fluidic Analytics operates a portfolio of protein interaction analysis tools built around its proprietary Microfluidic Diffusional Sizing (MDS) technology, which was developed at the University of Cambridge chemistry department and exploits laminar flow in microfluidic channels to measure protein hydrodynamic radius, binding affinity (KD), stoichiometry, and concentration directly in solution without purification or immobilization. The company is in the process of transitioning its commercial operations under the Fluidic Sciences Ltd entity, founded in 2024 by a small group of local investors to commercialize the MDS platform, while continuing to operate from Royston, UK, with a team of approximately 13–50 employees. Its product suite centers on the Fluidity One-M benchtop instrument, paired with single-use chip-plate consumables, protein labelling kits, the Fluidity Insight cloud analysis platform (with ML-guided and Bayesian assay design), and a growing menu of dedicated assays (NeSt for disordered proteins, SAffCon for serum antibody profiling, MAffCon for membrane proteins).

The business model combines one-time instrument sales with recurring consumables revenue (chip-plates and labelling kits, both shipped with a 3-month minimum shelf life), an annual SaaS subscription for Fluidity Insight, and optional professional services for installation and maintenance. Distribution is hybrid: direct enterprise sales for global accounts complemented by three regional distributors covering Eastern Europe and Austria (LKB), Japan (M&S TechnoSystems), and Taiwan and China (CS Biotech), giving the company coverage of roughly 15 countries despite its small headcount. In September 2025 the company acquired Sphere Bio, adding the Cyto-Mine Chroma picodroplet microfluidic single-cell screening platform and shifting the portfolio toward an end-to-end "cells to molecules" workflow. Primary customer segments are academic research institutions and biopharmaceutical companies, with an emerging clinical-laboratory vertical supported by the SAffCon assay. The firm has historically raised approximately $40.7M in venture funding (notably a $31M Series 3 in November 2018 led by Molten Ventures), though the post-restructuring Fluidic Sciences Ltd entity has not disclosed institutional venture rounds to date.

Name

Fluidic Analytics

Legal name

Fluidic Sciences Ltd

Website

https://fluidic.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Fluidic Analytics (operating as Fluidic Sciences Ltd) develops and commercializes the Microfluidic Diffusional Sizing (MDS) benchtop platform and consumables for measuring protein interactions in solution, serving academic researchers, biopharmaceutical companies, and clinical laboratories across roughly 15 countries.

Ownership category

akta.pro rank

Product category

Laboratory Instruments for Protein Interaction Analysis

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD)

Keywords

• Protein interaction analysis
• Microfluidic lab instruments
• Biophysical characterization tools
• Single-cell screening platforms
• Protein analysis consumables

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Instrument Sales: Sale of Fluidity One-M instruments for protein interaction analysis. Instruments include 12-month warranty covering parts, labour, and technical support.
2. Consumables: Recurring revenue from single-use chip-plates and protein labelling kits. Consumables shipped with minimum 3-month shelf life.
3. Cloud-based Software (SaaS): Cloud-based software platform (Fluidity Insight) for data analysis and machine learning-guided assay design.
4. Professional Services: Field service engineers provide installation, maintenance, and repair services. Annual maintenance recommended post-warranty.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Fluidic Sciences designs, develops and manufactures benchtop microfluidic instruments and single-use consumables for protein interaction analysis. Its proprietary Microfluidic Diffusional Sizing (MDS) technology measures binding affinity (KD), hydrodynamic radius, concentration and stoichiometry directly in solution, without purification or immobilization, in approximately 25 minutes. The portfolio also includes the Fluidity Insight cloud analysis platform and, following the 2025 acquisition of Sphere Bio, the Cyto-Mine Chroma picodroplet microfluidic platform for high-throughput single-cell screening.

Product overview

Fluidic Sciences offers an integrated portfolio of protein interaction analysis products built around their proprietary Microfluidic Diffusional Sizing (MDS) technology. The core offering includes the Fluidity One-M benchtop instrument paired with the Fluidity Insight cloud-based analysis platform featuring machine learning-guided assays and Bayesian analysis. Following the 2025 acquisition of Sphere Bio, the portfolio expanded to include the Cyto-Mine Chroma picodroplet microfluidic platform for single-cell analysis. Supporting consumables include chip-plates and protein labeling kits. Specialized assays (NeSt, SAffCon, MAffCon) address specific applications including intrinsically disordered proteins, serum antibody profiling, and membrane protein characterization.

Differentiator

Problem solved

Functional benefit

Brands

• Sphere Bio: High-throughput single-cell screening brand offering Cyto-MINE Chroma platform, picodroplet microfluidic technology, consumables, and reagents for biologics discovery, cell engineering, and synthetic biology applications.

Products and services

• Fluidity One-M Benchtop instrument using Microfluidic Diffusional Sizing (MDS) to measure protein interactions directly in solution. Delivers binding affinity (KD), hydrodynamic radius, concentration, and stoichiometry simultaneously in approximately 25 minutes from a 4 µL sample, without purification or immobilization. Targeted at academic research labs, biopharmaceutical R&D teams, and clinical laboratories.
• Fluidity Insight Cloud-based SaaS analysis platform that simplifies assay development for protein interaction analysis using machine learning-guided experimental design and Bayesian inference. License is provided on an annual subscription basis for the duration of the contract term.
• Cyto-Mine Chroma High-throughput picodroplet microfluidic platform from the acquired Sphere Bio business for single-cell isolation and analysis. Each picodroplet encapsulates a cell as an ultra-miniaturized test tube, enabling large-scale single-cell experiments in biologics discovery, cell engineering and synthetic biology.
• Fluidity One-M Chip-plates Single-use disposable microfluidic chip-plates with PEG-displaying anti-adhesive coating for use with the Fluidity One-M instrument. Sold in boxes of eight chip-plates, shipped with a minimum 3-month shelf life, designed to prevent cross-contamination between measurements.
• Protein Labelling Kit - Amine Reactive (Red 647 nm) Fluorescent labelling kit for tagging proteins for use in Fluidity One-M MDS experiments. Each kit contains material sufficient for six labelling reactions and is shipped with a minimum 3-month shelf life.
• Neuroaffinity and Stoichiometry (NeSt) Assay Dedicated MDS assay for determining both binding affinity and stoichiometry of protein interactions without external calibrants. Particularly suited to intrinsically disordered proteins such as alpha-synuclein, using Bayesian inference to provide a complete view of parameter space.
• Serum Affinity and Concentration (SAffCon) Assay Assay for measuring binding affinity and concentration of antibodies directly in whole biofluids including undiluted serum, requiring no pre-dilution or pretreatment of the sample.
• Membrane protein Affinity and Concentration (MAffCon) Assay Assay enabling absolute measurements of oncoprotein levels and antibody interactions in native lipid environments, including measurements in liposomes, lipid rafts, or nanodiscs.

Quantifiable outcome

• Full binding curve and KD determined in 25 minutes
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered flagship and core.

• Sphere BioflagshipStrategic or Co-development Partner · 4 September 2025Fluidic Sciences acquired the business and assets of Sphere Bio in September 2025. This combined portfolio unites Fluidic Sciences' in-solution Microfluidic Diffusional Sizing (MDS) technology with Sphere Bio's proprietary picodroplet-microfluidic platforms, Cyto-Mine® Chroma, and high-throughput assays. The acquisition delivers end-to-end insight from cells to molecules.
• LKBcoreChannel Partner/ Reseller/ DistributorRegional distributor for Eastern Europe covering Bosnia and Herzegovina, Bulgaria, Croatia, Serbia, Slovenia, Romania, Montenegro, Macedonia, Kosovo, Albania, and Austria. Provides product information, demonstrations, training, and support services for Fluidic Sciences products in the region.
• M&S TechnoSystems Inc.coreChannel Partner/ Reseller/ DistributorRegional distributor for Japan providing product information, demonstrations, training, and support services for Fluidic Sciences products. Located in Osaka, Japan.
• CS BiotechcoreChannel Partner/ Reseller/ DistributorRegional distributor for Taiwan and China providing product information, demonstrations, training, and support services for Fluidic Sciences products.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Sartorius (FortéBio): Sartorius owns FortéBio, whose BLI (Bio-Layer Interferometry) Octet platform is the most established label-free protein interaction analysis tool. Competes head-on with Fluidity One-M for protein binding affinity and kinetics workflows in pharma and academia.
• Cytiva (Biacore): Cytiva's Biacore SPR systems are the gold standard for surface-based protein interaction kinetics, occupying large installed bases in pharma and academic biophysics. Directly competes with MDS on binding affinity measurement but uses a fundamentally different surface-immobilization approach that MDS positions against.
• NanoTemper Technologies: NanoTemper's Monolith series (MST, MicroScale Thermophoresis) provides label-free protein interaction analysis in solution with low sample consumption. Closely comparable in value proposition to MDS, addressing the same use cases in biologics discovery and characterization.
• Wyatt Technology (Malvern Panalytical): Wyatt's DLS/SEC-MALS instruments (now under Malvern Panalytical) measure protein hydrodynamic radius and absolute molar mass. Adjacent technology to MDS for protein sizing, and an established competitor in protein characterization workflows.
• Unchained Labs: Unchained Labs builds protein analysis tools targeting biologics development workflows, including stability, aggregation, and interactomics. Competes for similar biopharma capex budget on protein characterization benches.

Emerging players

• Refeyn: Refeyn commercializes mass photometry for single-molecule mass measurement of proteins and other biomolecules. Emerging label-free, low-sample tool that overlaps with MDS on native-state protein sizing and binding analysis.
• Sphere Bio (now part of Fluidic Sciences): Sphere Bio was acquired by Fluidic Sciences in September 2025. Its Cyto-Mine picodroplet single-cell screening platform is now a sister product inside the combined Fluidic Sciences portfolio and a reference point for the broader single-cell microfluidic tool category.

Broad incumbents

• Molecular Devices (Danaher): Molecular Devices supplies a broad portfolio of biophysics and screening instruments including high-content screening and protein interaction tools. Competes indirectly with MDS through larger workflow-level deals with biopharma accounts.
• Bruker: Bruker offers a broad suite of biophysical and analytical instruments (SPR, MS, NMR) used in structural biology and protein research. A scale incumbent that can bundle alternatives to MDS into large pharma enterprise deals.
• 10x Genomics: 10x Genomics' Chromium platform provides droplet-based single-cell isolation and analysis widely used in cell biology and antibody discovery. Comparable to Sphere Bio's Cyto-Mine for high-throughput single-cell screening applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/fluidicanalytic
• LinkedInlinkedin.com/company/fluidic-analytics
• Facebookfacebook.com/FluidicAnalytic

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluidic Analytics